ILLUMINA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
ILLUMINA, INC. (ILMN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $308.00 million for the 9-month period ending 2024-09-29, per its 10-Q filed 2024-11-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2024-11-06
- ILLUMINA, INC. effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2024-03-31 was $21.00M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 month |
|---|---|---|
| 2024-09-29 | $308.00M 10-Q · filed 2024-11-06 | |
| 2024-03-31 | $21.00M 10-Q · filed 2024-05-03 | |
| 2023-10-01 | $149.00M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |